Janice R. Andrews
Apple has conducted internal testing of a novel blood glucose tracking application, focusing on individuals at risk of diabetes. Bloomberg reporter Mark Gurman reveals that the software is designed to help users understand how their blood sugar levels fluctuate in relation to their food choices, though commercial availability remains undetermined.
The trial engaged Apple staff members with Type 2 diabetes risk factors, who utilized existing glucose monitoring devices. Participants could document their glucose measurements and identify dietary patterns, helping them recognize which foods might impact their blood sugar stability.
This software initiative runs parallel to Apple’s long-term hardware development goals. The company’s 15-year quest to create a non-invasive glucose measurement device continues, with current prototypes matching iPhone dimensions. While future wearables might eventually flag pre-diabetes risk factors, achieving precise glucose measurement capability may require further development time.
The experiment suggests Apple’s growing commitment to expanding its health monitoring capabilities, despite the current Apple Health platform lacking comprehensive meal-tracking features found in competing apps. Enhanced glucose monitoring integration could strengthen Apple’s position in providing advanced health management solutions to its user base.
